1. Home
  2. ACOG vs AXTI Comparison

ACOG vs AXTI Comparison

Compare ACOG & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • AXTI
  • Stock Information
  • Founded
  • ACOG 2000
  • AXTI 1986
  • Country
  • ACOG Canada
  • AXTI United States
  • Employees
  • ACOG N/A
  • AXTI N/A
  • Industry
  • ACOG
  • AXTI Semiconductors
  • Sector
  • ACOG
  • AXTI Technology
  • Exchange
  • ACOG Nasdaq
  • AXTI Nasdaq
  • Market Cap
  • ACOG 80.3M
  • AXTI 94.4M
  • IPO Year
  • ACOG N/A
  • AXTI 1998
  • Fundamental
  • Price
  • ACOG $8.00
  • AXTI $2.05
  • Analyst Decision
  • ACOG Strong Buy
  • AXTI Strong Buy
  • Analyst Count
  • ACOG 1
  • AXTI 4
  • Target Price
  • ACOG $20.00
  • AXTI $4.60
  • AVG Volume (30 Days)
  • ACOG 66.4K
  • AXTI 242.8K
  • Earning Date
  • ACOG 08-14-2025
  • AXTI 07-31-2025
  • Dividend Yield
  • ACOG N/A
  • AXTI N/A
  • EPS Growth
  • ACOG N/A
  • AXTI N/A
  • EPS
  • ACOG N/A
  • AXTI N/A
  • Revenue
  • ACOG $4,586,341.00
  • AXTI $86,080,000.00
  • Revenue This Year
  • ACOG N/A
  • AXTI N/A
  • Revenue Next Year
  • ACOG $149.89
  • AXTI $29.07
  • P/E Ratio
  • ACOG N/A
  • AXTI N/A
  • Revenue Growth
  • ACOG N/A
  • AXTI N/A
  • 52 Week Low
  • ACOG $3.75
  • AXTI $1.13
  • 52 Week High
  • ACOG $11.54
  • AXTI $3.07
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • AXTI 44.66
  • Support Level
  • ACOG N/A
  • AXTI $1.96
  • Resistance Level
  • ACOG N/A
  • AXTI $2.24
  • Average True Range (ATR)
  • ACOG 0.00
  • AXTI 0.15
  • MACD
  • ACOG 0.00
  • AXTI -0.02
  • Stochastic Oscillator
  • ACOG 0.00
  • AXTI 31.25

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

Share on Social Networks: